Sio Gene Therapies Inc. (NASDAQ: SIOX) flaunted slowness of -7.02% at $2.65, as the Stock market unbolted on April 05, 2021. During the day, the stock rose to $2.85 and sunk to $2.63 before settling in for the price of $2.85 at the close. Taking a more long-term approach, SIOX posted a 52-week range of $1.86-$5.74.
Meanwhile, its Annual Earning per share during the time was -10.10%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 63.50%. This publicly-traded company’s shares outstanding now amounts to $46.73 million, simultaneously with a float of $40.05 million. The organization now has a market capitalization sitting at $142.54 million. At the time of writing, stock’s 50-day Moving Average stood at $2.79, while the 200-day Moving Average is $3.01.
Sio Gene Therapies Inc. (SIOX) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Sio Gene Therapies Inc. industry. Sio Gene Therapies Inc.’s current insider ownership accounts for 0.40%, in contrast to 25.40% institutional ownership. According to the most recent insider trade that took place on Mar 23, this organization’s Chief Executive Officer bought 100,000 shares at the rate of 2.48, making the entire transaction reach 248,180 in total value, affecting insider ownership by 180,426. Preceding that transaction, on Nov 24, Company’s Director bought 10,000 for 2.34, making the whole transaction’s value amount to 23,399. This particular insider is now the holder of 33,370 in total.
Sio Gene Therapies Inc. (SIOX) Earnings and Revenue Records
Going through the last 3-months fiscal report unveiled on the 12/30/2020, it has been observed that the corporation posted -$0.2 earnings per share (EPS) during the time that was better the consensus figure (set at -$0.29) by $0.09. This company achieved a return on equity of -123.34. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.22 per share during the current fiscal year.
Sio Gene Therapies Inc.’s EPS increase for this current 12-month fiscal period is 63.50% and is forecasted to reach -0.89 in the upcoming year.
Sio Gene Therapies Inc. (NASDAQ: SIOX) Trading Performance Indicators
Let’s observe the current performance indicators for Sio Gene Therapies Inc. (SIOX). It’s Quick Ratio in the last reported quarter now stands at 7.00. The Stock has managed to achieve an average true range (ATR) of 0.22.
In the same vein, SIOX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.15, a figure that is expected to reach -0.21 in the next quarter, and analysts are predicting that it will be -0.89 at the market close of one year from today.
Technical Analysis of Sio Gene Therapies Inc. (SIOX)
Now, what If we examine the latest scores posted by [Sio Gene Therapies Inc., SIOX]. During the last 5-days, its volume was lower the volume of 1.58 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 78.24% While, its Average True Range was 0.21.
Raw Stochastic average of Sio Gene Therapies Inc. (SIOX) in the period of the previous 100 days is set at 33.33%, which indicates a major fall in contrast to 56.20% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 80.29% that was higher than 79.75% volatility it exhibited in the past 100-days period.